El año pasado, Teva Pharmaceutical Industries Ltd generó 9.42B USD en su segmento con mejor rendimiento, Generic products. United States realizó la mayor aportación, representando 9.19B USD el año pasado. Para el último trimestre, Teva Pharmaceutical Industries Ltd reportó unos ingresos de 2.10B USD para el periodo finalizado el 2026-06-30, procedentes del segmento con mejor rendimiento, Generic products. United States aportó los mayores ingresos, alcanzando los 1.70B USD.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Generic products

AUSTEDO

Other

Anda

AJOVY

COPAXONE

Respiratory products

UZEDY

BENDEKA / TREANDA

ProAir

QVAR

Distribution

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

Generic products

9.42B(57.48%)

9.46B(60.65%)

8.73B(58.54%)

8.60B(61.97%)

8.99B(61.03%)

9.31B(60.66%)

9.33B(59.84%)

9.67B(55.30%)

11.04B(52.59%)

10.94B(52.68%)

AUSTEDO

2.26B(13.79%)

1.69B(10.82%)

1.24B(8.31%)

963.00M(6.94%)

802.00M(5.45%)

637.00M(4.15%)

412.00M(2.64%)

204.00M(1.17%)

24.00M(0.11%)

--(--)

Other

1.51B(9.19%)

1.38B(8.82%)

1.82B(12.19%)

1.19B(8.56%)

1.38B(9.34%)

1.25B(8.16%)

1.36B(8.70%)

1.68B(9.58%)

2.59B(12.34%)

2.97B(14.30%)

Anda

1.50B(9.13%)

1.54B(9.85%)

1.58B(10.57%)

1.47B(10.60%)

1.32B(8.98%)

1.46B(9.52%)

1.49B(9.57%)

1.35B(7.70%)

1.15B(5.49%)

301.00M(1.45%)

AJOVY

673.00M(4.11%)

507.00M(3.25%)

434.00M(2.91%)

377.00M(2.72%)

313.00M(2.13%)

165.00M(1.07%)

93.00M(0.60%)

--(--)

COPAXONE

468.00M(2.86%)

503.00M(3.22%)

591.00M(3.96%)

691.00M(4.98%)

1.00B(6.82%)

1.34B(8.71%)

1.51B(9.70%)

2.37B(13.53%)

3.80B(18.10%)

4.22B(20.34%)

Respiratory products

227.00M(1.38%)

244.00M(1.56%)

265.00M(1.78%)

273.00M(1.97%)

356.00M(2.42%)

353.00M(2.30%)

354.00M(2.27%)

402.00M(2.30%)

368.00M(1.75%)

239.00M(1.15%)

UZEDY

191.00M(1.17%)

117.00M(0.75%)

23.00M(0.15%)

--(--)

BENDEKA / TREANDA

147.00M(0.90%)

168.00M(1.08%)

237.00M(1.59%)

316.00M(2.28%)

385.00M(2.61%)

415.00M(2.70%)

496.00M(3.18%)

642.00M(3.67%)

656.00M(3.12%)

661.00M(3.18%)

ProAir

--(--)

180.00M(1.22%)

241.00M(1.57%)

274.00M(1.76%)

397.00M(2.27%)

501.00M(2.39%)

565.00M(2.72%)

QVAR

--(--)

179.00M(1.17%)

250.00M(1.60%)

182.00M(1.04%)

313.00M(1.49%)

409.00M(1.97%)

Distribution

--(--)

20.00M(0.13%)

602.00M(3.44%)

550.00M(2.62%)

458.00M(2.21%)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

United States

Europe

International Markets

Other

North America

North America.

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States

9.19B(53.22%)

8.03B(48.56%)

7.73B(48.80%)

--(--)

Europe

5.04B(29.20%)

5.10B(30.84%)

4.84B(30.52%)

4.52B(30.31%)

4.89B(30.77%)

4.76B(28.55%)

4.79B(28.39%)

5.19B(27.51%)

5.47B(24.42%)

4.97B(14.81%)

4.89B(24.88%)

5.82B(28.72%)

5.99B(29.48%)

5.80B(28.54%)

5.80B(31.66%)

International Markets

2.16B(12.53%)

2.46B(14.89%)

2.35B(14.84%)

1.90B(12.75%)

2.03B(12.79%)

2.15B(12.93%)

2.25B(13.30%)

3.00B(15.94%)

3.40B(15.17%)

4.01B(11.97%)

3.51B(17.88%)

3.81B(18.82%)

3.87B(19.03%)

4.08B(20.09%)

3.71B(20.29%)

Other

870.00M(5.04%)

944.00M(5.71%)

926.00M(5.84%)

1.04B(7.00%)

1.15B(7.25%)

1.30B(7.82%)

1.30B(7.72%)

1.37B(7.25%)

1.38B(6.18%)

1.14B(3.40%)

--(--)

North America

--(--)

7.45B(49.94%)

7.81B(49.18%)

8.45B(50.71%)

8.54B(50.58%)

9.30B(49.31%)

12.14B(54.24%)

11.78B(35.10%)

--(--)

10.44B(51.38%)

8.80B(48.06%)

North America.

--(--)

11.65B(34.72%)

11.25B(57.24%)

10.63B(52.46%)

10.46B(51.50%)

--(--)